Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure

Abstract Acute liver failure (ALF) is a hepatology emergency with rapid hepatic destruction, multiple organ failures, and high mortality. Despite decades of research, established ALF has minimal therapeutic options. Here, we report that the small bioactive compound SCM-198 increases the survival of...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Wang, Youwei Chen, Jiazhen Han, Huikang Ye, Huiran Yang, Qianyan Li, Yizhen He, Boyu Ma, Junjie Zhang, Yanli Ge, Zhe Wang, Bo Sun, Huahua Liu, Liming Cheng, Zhirong Wang, Gufa Lin
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-55295-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846112424136015872
author Rui Wang
Youwei Chen
Jiazhen Han
Huikang Ye
Huiran Yang
Qianyan Li
Yizhen He
Boyu Ma
Junjie Zhang
Yanli Ge
Zhe Wang
Bo Sun
Huahua Liu
Liming Cheng
Zhirong Wang
Gufa Lin
author_facet Rui Wang
Youwei Chen
Jiazhen Han
Huikang Ye
Huiran Yang
Qianyan Li
Yizhen He
Boyu Ma
Junjie Zhang
Yanli Ge
Zhe Wang
Bo Sun
Huahua Liu
Liming Cheng
Zhirong Wang
Gufa Lin
author_sort Rui Wang
collection DOAJ
description Abstract Acute liver failure (ALF) is a hepatology emergency with rapid hepatic destruction, multiple organ failures, and high mortality. Despite decades of research, established ALF has minimal therapeutic options. Here, we report that the small bioactive compound SCM-198 increases the survival of male ALF mice to 100%, even administered 24 hours after ALF establishment. We identify adiponectin receptor 2 (AdipoR2) as a selective target of SCM-198, with the AdipoR2 R335 residue being critical for the binding and signaling of SCM-198-AdipoR2 and AdipoR2 Y274 residue serving as a molecular switch for Ca2+ influx. SCM-198-AdipoR2 binding causes Ca2+ influx and elevates the phosphorylation levels of CaMKII and NOS3 in the AdipoR2-CaM-CaMKII-NOS3 complex identified in this study, rapidly inducing nitric oxide production for liver protection in murine ALF. SCM-198 also protects human ESC-derived liver organoids from APAP/TAA injuries. Thus, selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 is a rapid-acting therapeutic strategy for advanced ALF.
format Article
id doaj-art-899ae713e8fd4fc8a0b92b9b00ba4673
institution Kabale University
issn 2041-1723
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-899ae713e8fd4fc8a0b92b9b00ba46732024-12-22T12:36:26ZengNature PortfolioNature Communications2041-17232024-12-0115112210.1038/s41467-024-55295-7Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failureRui Wang0Youwei Chen1Jiazhen Han2Huikang Ye3Huiran Yang4Qianyan Li5Yizhen He6Boyu Ma7Junjie Zhang8Yanli Ge9Zhe Wang10Bo Sun11Huahua Liu12Liming Cheng13Zhirong Wang14Gufa Lin15Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityDepartment of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji UniversityKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedic, Tongji Hospital affiliated to Tongji University, School of Life Sciences and Technology, Tongji UniversityAbstract Acute liver failure (ALF) is a hepatology emergency with rapid hepatic destruction, multiple organ failures, and high mortality. Despite decades of research, established ALF has minimal therapeutic options. Here, we report that the small bioactive compound SCM-198 increases the survival of male ALF mice to 100%, even administered 24 hours after ALF establishment. We identify adiponectin receptor 2 (AdipoR2) as a selective target of SCM-198, with the AdipoR2 R335 residue being critical for the binding and signaling of SCM-198-AdipoR2 and AdipoR2 Y274 residue serving as a molecular switch for Ca2+ influx. SCM-198-AdipoR2 binding causes Ca2+ influx and elevates the phosphorylation levels of CaMKII and NOS3 in the AdipoR2-CaM-CaMKII-NOS3 complex identified in this study, rapidly inducing nitric oxide production for liver protection in murine ALF. SCM-198 also protects human ESC-derived liver organoids from APAP/TAA injuries. Thus, selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 is a rapid-acting therapeutic strategy for advanced ALF.https://doi.org/10.1038/s41467-024-55295-7
spellingShingle Rui Wang
Youwei Chen
Jiazhen Han
Huikang Ye
Huiran Yang
Qianyan Li
Yizhen He
Boyu Ma
Junjie Zhang
Yanli Ge
Zhe Wang
Bo Sun
Huahua Liu
Liming Cheng
Zhirong Wang
Gufa Lin
Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
Nature Communications
title Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
title_full Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
title_fullStr Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
title_full_unstemmed Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
title_short Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
title_sort selectively targeting the adipor2 cam camkii nos3 axis by scm 198 as a rapid acting therapy for advanced acute liver failure
url https://doi.org/10.1038/s41467-024-55295-7
work_keys_str_mv AT ruiwang selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT youweichen selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT jiazhenhan selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT huikangye selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT huiranyang selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT qianyanli selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT yizhenhe selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT boyuma selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT junjiezhang selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT yanlige selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT zhewang selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT bosun selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT huahualiu selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT limingcheng selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT zhirongwang selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure
AT gufalin selectivelytargetingtheadipor2camcamkiinos3axisbyscm198asarapidactingtherapyforadvancedacuteliverfailure